RSCH Statistics

Total Valuation

PT Charlie Hospital Semarang Tbk has a market cap or net worth of IDR 938.10 billion. The enterprise value is 973.91 billion.

Market Cap	938.10B
Enterprise Value	973.91B

Important Dates

The last earnings date was Tuesday, October 29, 2024.

Earnings Date	Oct 29, 2024
Ex-Dividend Date	n/a

Share Statistics

PT Charlie Hospital Semarang Tbk has 2.65 billion shares outstanding. The number of shares has increased by 21.82% in one year.

Current Share Class	n/a
Shares Outstanding	2.65B
Shares Change (YoY)	+21.82%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.57%
Owned by Institutions (%)	n/a
Float	530.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.08
PB Ratio	6.24
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 149.70, with an EV/FCF ratio of -34.76.

EV / Earnings	-1,855.14
EV / Sales	20.40
EV / EBITDA	149.70
EV / EBIT	n/a
EV / FCF	-34.76

Financial Position

The company has a current ratio of 0.99, with a Debt / Equity ratio of 0.27.

Current Ratio	0.99
Quick Ratio	0.80
Debt / Equity	0.27
Debt / EBITDA	6.13
Debt / FCF	-1.42
Interest Coverage	0.67

Financial Efficiency

Return on equity (ROE) is -0.35% and return on invested capital (ROIC) is 0.10%.

Return on Equity (ROE)	-0.35%
Return on Assets (ROA)	0.10%
Return on Capital (ROIC)	0.10%
Revenue Per Employee	221.00M
Profits Per Employee	-2.43M
Employee Count	212
Asset Turnover	0.27
Inventory Turnover	31.69

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +174.02% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+174.02%
50-Day Moving Average	366.68
200-Day Moving Average	252.02
Relative Strength Index (RSI)	40.15
Average Volume (20 Days)	2,976,425

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PT Charlie Hospital Semarang Tbk had revenue of IDR 47.74 billion and -524.98 million in losses. Loss per share was -0.23.

Revenue	47.74B
Gross Profit	14.57B
Operating Income	278.04M
Pretax Income	-367.91M
Net Income	-524.98M
EBITDA	6.51B
EBIT	278.04M
Loss Per Share	-0.23

Full Income Statement

Balance Sheet

The company has 4.09 billion in cash and 39.90 billion in debt, giving a net cash position of -35.81 billion or -13.51 per share.

Cash & Cash Equivalents	4.09B
Total Debt	39.90B
Net Cash	-35.81B
Net Cash Per Share	-13.51
Equity (Book Value)	150.22B
Book Value Per Share	56.69
Working Capital	-61.15M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.34 billion and capital expenditures -34.36 billion, giving a free cash flow of -28.02 billion.

Operating Cash Flow	6.34B
Capital Expenditures	-34.36B
Free Cash Flow	-28.02B
FCF Per Share	-10.57

Full Cash Flow Statement

Margins

Gross margin is 30.53%, with operating and profit margins of 0.58% and -1.10%.

Gross Margin	30.53%
Operating Margin	0.58%
Pretax Margin	-0.77%
Profit Margin	-1.10%
EBITDA Margin	13.63%
EBIT Margin	0.58%
FCF Margin	-58.70%

Dividends & Yields

PT Charlie Hospital Semarang Tbk does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.82%
Shareholder Yield	-21.82%
Earnings Yield	-0.06%
FCF Yield	-2.99%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PT Charlie Hospital Semarang Tbk has an Altman Z-Score of 6.95.

Altman Z-Score	6.95
Piotroski F-Score	n/a